Original Research and the Latest News
Recent Posts
Letting the Data Tell the Story
In our previous post we described the technique for assigning categories to data, based on input from content experts within a...
Keeping up with the Pharmaceutical Industry in Asia
Keeping up with the pharmaceutical landscape around the world, especially in Asia, is essential in today’s market. Here are some...
Merck Diabetes Pipeline Analysis
Merck’s two blockbuster diabetes products, Janumet® and Januvia®, are DPP-4 inhibitors that generated nearly $3.3 billion in...
The Future of Innovation in Diabetes & Heart Disease
When it comes to improving the lives of patients with chronic illnesses like type-2 diabetes and heart disease, the...
New Faces in Big Pharma & the Rise of the Billion Dollar Deal
M&A mania is here. Unprecedented deal values for mergers and acquisitions dominated in 2014. Worldwide M&A was up...
Novo Nordisk Diabetes Pipeline Analysis
Novo Nordisk remains a top player in the Diabetes market with blockbuster insulins NovoLog® and Levemir® which brought in a...
Pharma Forecasting Case Study – Valuing the Impact of Development Delays
A multinational pharmaceutical firm asked Ozmosi to provide forecasts to assess the market impact of delays in delivering new...
Covid-19 Clinical Trials and Where to Get Treated Update
Here is a quick update on the ever-evolving world of COVID-19 trials. Since our initial posting on this topic three weeks ago,...
Using NLP Data to Classify Patient Segments in Clinical Trial Data
One of the most common and powerful approaches in NLP provides the content experts an opportunity to label each data segment for...
Pharma Forecasting Case Study – Shaping R&D Strategy
The oncology team of a major multinational pharmaceutical company asked Ozmosi to provide additional forecasting support for a...
Case Study Portfolio – Prioritization aligning teams on value and risk and guiding investment
The Asia-Pacific R&D unit of a large, multinational pharmaceutical company needed a pipeline prioritization approach to...
When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency
Predicting when a competing product will be approved is essential in any commercial forecast and for any business insights team...
ELI LILLY in the Diabetes Market
For years, Eli Lilly’s main contributions to the Diabetes market were their insulins: fast-acting analog Humalog® and human...
What do the big players have in store for the Diabetes market in the next 12 months?
Diabetes is one of the most prevalent diseases in the U.S., afflicting over 29 million people across Type 1 and Type 2 patients,...
Case Study Market Scan – Understanding the Competition and Defining Opportunity
A small startup medical device company needed a broader understanding of its potential competitors and a more complete picture...
PHARMA FORECASTING CASE STUDY – Estimating the Prevalence of Orphan Diseases
When in-house experts’ forecasts for the market potential of a treatment for an orphan disease conflicted, the management team...
Case Study Market Scan – Surveying Pharmaceutical Markets in Asia Pacific
A regional marketing team for a multinational pharmaceutical company needed a complete market overview of a neuroscience therapy...
A Gift for Patients – Medicare to Cover Lung Cancer Screening
LUNG CANCER SCREENING UPDATE: As of February 5, 2015, effective immediately, Medicare will cover lung cancer screening by...
Recent Tweets
🚀🚨 BIOPHARM CATALYST ALERT 📆
$IVBIY Innovent Biologics will present Phase 3 Type 2 Diabetes Data for Mazdutide (GLP-1 Agonist - Peptide/Protein) tomorrow 👀
🚀🚨 BIOPHARM CATALYST ALERT 📆
$AMGN Amgen will present Phase 2 Obesity Data for Maridebart cafraglutide (GLP-1 Agonist - Peptide/Protein) tomorrow 👀
Get Started with OZMOSI
We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.
600 Warren Ave,
Spring Lake, NJ 07762